back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-04-02 16:07 Tx date 2022-03-31 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,973
+6,800 vol $1.47 each |
123,786 | |
| Filed 2022-01-05 16:46 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+80,250 vol |
195,750 | |
| Filed 2022-01-05 16:44 Tx date 2022-01-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+53,500 vol |
383,408 | |
| Filed 2021-06-24 11:56 Tx date 2021-06-23 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,218
+2,200 vol $1.46 each |
116,986 | |
| Filed 2021-06-24 11:53 Tx date 2021-06-22 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,904
+2,700 vol $1.45 each |
114,786 | |
| Filed 2021-06-22 15:45 Tx date 2021-06-21 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,871
+2,000 vol $1.44 each |
112,086 | |
| Filed 2021-03-23 11:50 Tx date 2021-03-22 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,849
+4,700 vol $1.67 each |
110,086 | |
| Filed 2021-03-23 11:43 Tx date 2020-03-27 |
$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
299,908 | |
| Filed 2020-03-27 16:05 Tx date 2020-03-27 |
$MRV
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
||
| Filed 2021-03-18 09:32 Tx date 2021-03-16 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,062
+6,500 vol $1.86 each |
105,386 | |
| Filed 2021-03-12 16:08 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+115,500 vol |
115,500 | |
| Filed 2021-03-12 16:02 Tx date 2016-04-04 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-12 15:59 Tx date 2021-03-11 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
329,908 | |
| Filed 2020-06-17 12:47 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+1,500 vol $0.80 each |
98,886 | |
| Filed 2020-06-17 12:46 Tx date 2020-06-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
97,386 | |
| Filed 2020-06-15 16:54 Tx date 2020-06-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
94,886 | |
| Filed 2020-06-12 13:23 Tx date 2020-06-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
92,386 | |
| Filed 2020-06-11 13:56 Tx date 2020-06-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
89,886 | |
| Filed 2020-06-10 13:25 Tx date 2020-06-09 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
87,386 | |
| Filed 2020-06-09 13:40 Tx date 2020-06-08 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
84,886 |